UURL 財經新聞FINANCE
UURL Finance · Taiwan market + in-depth rewrites · hourly

ASE to Spend US$11.5 Billion on Expansion, Target Price NT$900

Browser TTS · no download

30-second brief

ASE Technology Holding's Q3 assembly and testing revenue rose 20.4% QoQ, with gross margin of 30.6% beating guidance. Analysts raised the Q4 outlook, lifted 2026 capital expenditure to US$11.5 billion, estimated EPS at NT$21.38, raised the target price to NT$900, and maintained a Buy rating.

Q3 Assembly and Testing Beat Guidance

ASE Technology Holding Q3 assembly and testing revenue grew 20.4% QoQ, better than the original estimate of 11% to 13%. Quarterly gross margin reached 30.6%, above the guided range of 28% to 29% and also above the upper end of the company's structural gross margin of 25% to 30%. Quarterly after-tax EPS was NT$6.05, about 12% higher than analysts' original estimate of NT$5.41, mainly driven by advanced semiconductor packaging and testing demand. Q3 operating performance significantly exceeded original guidance, and the Q4 operating outlook also beat expectations.

Q4 Outlook Revised Up

Looking to Q4, benefiting from strong automotive, industrial and AI-peripheral demand, analysts raised the revenue forecast by 9.8% to NT$262.1 billion, up 7.4% QoQ and up 47.3% YoY, and raised EPS by 23% to NT$7.44. Among them, assembly and testing revenue is estimated to grow 11% to 13% QoQ, with gross margin estimated at 31.6% to 32.6%, continuing the growth momentum from Q3. Analysts are positive on the Q4 assembly and testing business and overall operations.

Capex Raised to US$11.5 Billion

To meet advanced packaging and testing demand, ASE further raised 2026 capital expenditure from US$10.5 billion to US$11.5 billion, an increase of US$1 billion, with plant and equipment investment each increasing by US$500 million. The upward revision shows the company continues to expand plant and equipment investment in line with customer demand and capacity planning to support subsequent growth in advanced packaging and LEAP-related businesses.

LEAP Business Estimated to Double in 2027

For the LEAP business, the 2026 revenue target was raised to US$4 billion, up 150% YoY, accounting for about 23% of assembly and testing revenue. Proprietary Full Process (FOCoS) is expected to start contributing revenue in Q4, at about US$300 million. Looking to 2027, with TSMC CoWoS expansion, a higher outsourced share of CP testing, and gradual ramp-up of FOCoS, the company maintains its view that LEAP revenue will double, with its share of assembly and testing revenue rising to 35.4%, of which FOCoS could reach 5.9%. Benefiting from advanced packaging demand and rapid LEAP business growth, analysts estimate 2026 and 2027 EPS at NT$21.38 and NT$34.04 respectively, up 11% and 23% from prior estimates, with a two-year profit CAGR likely exceeding 40%. Based on 2027 estimated EPS and a 25x P/E multiple, the target price is raised to NT$900, with a Buy rating maintained.

FAQ

What were the highlights of ASE's Q3 results?

Q3 assembly and testing revenue grew 20.4% QoQ, beating the estimate of 11% to 13%, gross margin of 30.6% was above the guided range of 28% to 29%, and after-tax EPS was NT$6.05, about 12% higher than analysts' original estimate of NT$5.41.

Why were capex and the target price raised?

To meet demand from automotive, industrial and AI-peripheral applications, the company raised 2026 capital expenditure from US$10.5 billion to US$11.5 billion. Based on 2027 estimated EPS of NT$34.04 and a 25x P/E multiple, analysts raised the target price to NT$900 and maintained a Buy rating.

What is the outlook for the LEAP business?

2026 LEAP revenue is targeted at US$4 billion, up 150% YoY, accounting for 23% of assembly and testing revenue, with FOCoS contributing about US$300 million in Q4; in 2027 LEAP revenue is estimated to double, accounting for 35.4% of assembly and testing revenue, of which FOCoS is estimated at 5.9%.